News Results
There are 77,400 News Results
Sep 11, 2018
FORT WORTH, Texas, Sept. 11, 2018 /PRNewswire/ -- Eyevance Pharmaceuticals, LLC, a Fort Worth-based pharmaceutical company committed to developing and commercializing innovative and impactful ophthalmic products, today announced the acquisition...
Sep 27, 2018
PLYMOUTH MEETING, Pa., Sept. 27, 2018 /PRNewswire/ -- Harmony Biosciences, LLC (Harmony) announced today that French pharmaceutical company Bioprojet SCR (Bioprojet) presented new human abuse potential (HAP) data on pitolisant...
Oct 2, 2018
Proprietary technology positioned to become the new standard of care in global drug delivery
May 30, 2017
NESS ZIONA, Israel, May 31, 2017 /PRNewswire/ -- CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human "rhCollagen") technology for tissue repair products, provided an...
Jun 12, 2017
LEXINGTON, Mass., June 13, 2017 /PRNewswire/ -- Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it...
Jun 18, 2017
PALO ALTO, Calif., June 19, 2017 /PRNewswire/ - Sciton, Inc. Women's Health Group today announced interim and final results of a pilot study of its novel diVa Hybrid Laser for...
Jul 27, 2017
TEMPE, Ariz. and SAN JUAN CAPISTRANO, Calif., July 28, 2017 /PRNewswire/ -- When Pinscriptive and T-Systems announced their partnership on December 8, 2016, http://www.prnewswire.com/news-releases/pinscriptive-and-t-systems-partner-to-deliver-cloud-based-specialty-drug-management-analytics-300374974.html the intent was to test the...
Aug 2, 2017
OCEAN VIEW, Del., Aug 3, 2017 /PRNewswire-iReach/ -- The Industry Share report "
Aug 24, 2017
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2017 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that Brian L. Kotzin, M.D. has been appointed to Rigel's board of directors. A well-respected...
Sep 28, 2017
HERTFORDSHIRE, England and PITTSBURGH, Sept. 29, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Imatinib Mesylate Tablets, 100 mg and 400 mg, a generic...